Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05543265
Other study ID # 2022P001723
Secondary ID P30AG034532P30AG
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date November 3, 2022
Est. completion date June 2024

Study information

Verified date October 2023
Source Massachusetts General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic health conditions affect most older adults. Preventative medicine and risk management strategies, especially when applied earlier in life, are essential to altering the trajectory of a disease and ultimately improving health outcomes. Primary care providers (PCP) often provide most of these services, though younger adults are the least likely to receive primary care. This project leverages a period of high engagement and health activation during an individual's life (pregnancy) to nudge her toward use of primary care after the pregnancy episode. This randomized controlled trial will test the hypothesis that a behavioral science-informed intervention, incorporating defaults and salience, can increase the rates of PCP follow-up within 4 months following a delivery for individual with hypertension, diabetes, obesity. If successful, this intervention could serve as a scalable solution to increase primary care use and preventative health services in a population that currently has low rates of engagement and utilization of these services.


Description:

Individuals will be randomized with equal probability into either a treatment or control arm. The intervention combines several features designed to target reasons for low take-up of primary care among postpartum individuals. This project will leverage the potential value of defaults/opt-out, salient information, and reminders to encourage use of primary care. Individuals in both the intervention and control arms will receive information via the study institution's patient portal toward the end of the pregnancy regarding the importance and benefits of primary care in the postpartum year. This information will be similar to, but reinforcing, the information they would receive from their obstetrician about following up with their primary care physician. In addition to this initial message, individuals in the treatment arm will receive the following intervention components, developed based on recent evidence regarding behavioral science approaches to activating health behaviors: 1. Targeted messages about the importance and benefits of primary care 2. Default scheduling into a primary care appointment at approximately 3-4 months after delivery 3. Reminders about the appointment and importance of follow up primary care at 2-4 points during the postpartum period via the patient portal 4. Tailored language in the reminders based on recent evidence from behavioral science about the most effective approaches to increasing take-up. For example, messages will inform the patient that an appointment is being held for them at their doctor. 5. Salient labeling on follow-up appointments 6. Direct PCP messaging about the scheduled follow-up


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 360
Est. completion date June 2024
Est. primary completion date October 11, 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Estimated date of delivery and the following 4-month postpartum outcome assessment window completed prior to study end date - Currently pregnant or within 2 weeks of delivery - Have one or more of the following conditions: 1) Chronic hypertension, 2) Hypertensive disorders of pregnancy or risk factors for hypertensive disorders of pregnancy per the USPSTF aspirin prescribing guidelines (e.g., history of pre-eclampsia, kidney disease, multiple gestation, autoimmune disease), 3) Type 1 or 2 diabetes, 4) Gestational diabetes, 5) Obesity (pre-pregnancy body mass index =30 kg/m2), 6) Depression or anxiety disorder - Have a primary care provider listed in the electronic health record (EHR) - Receive obstetric care at the study institution's outpatient prenatal clinic - Have access to and be enrolled in the EHR patient portal and consents to be contacted via these modalities - Able to read/speak English or Spanish language - Age =18 years old - Not actively known to have or undergoing work-up for fetal demise Exclusion Criteria: - No primary care provider listed in the EHR - Primary language other than English or Spanish - No access to online patient EHR portal

Study Design


Intervention

Behavioral:
Default appointment scheduling
Default primary care appointment scheduling
Targeted messaging
Patient-specific messages about the importance of postpartum care transition
Nudge Reminders
Primary care appointment reminders

Locations

Country Name City State
United States Massachusetts General Hospital Boston Massachusetts

Sponsors (4)

Lead Sponsor Collaborator
Massachusetts General Hospital Massachusetts Institute of Technology, National Bureau of Economic Research, Inc., National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of primary care provider visit attendance Any visit with 1) a primary care provider (e.g., internal medicine, family medicine, pediatrics, gynecology) and 2) receipt of "annual" or "health care maintenance" services OR disease-specific management (diabetes, hypertension, obesity, mental health) 4 months after the patient's estimated date of delivery
Secondary Rate of primary care provider visit attendance Any visit with 1) a primary care provider (e.g., internal medicine, family medicine, pediatrics, gynecology) and 2) receipt of "annual" or "health care maintenance" services OR disease-specific management (diabetes, hypertension, obesity, mental health) 12 months after the patient's estimated date of delivery
Secondary Rate of visit with a patient's assigned primary care provider for receipt of "annual" or "health care maintenance" services OR disease-specific management (diabetes, hypertension, obesity, mental health) Health care maintenance visit appointment with the patient's assigned primary care provider 4 months after the patient's estimated date of delivery
Secondary Rate of visit with a patient's assigned primary care provider for receipt of "annual" or "health care maintenance" services OR disease-specific management (diabetes, hypertension, obesity, mental health) Health care maintenance visit appointment with the patient's assigned primary care provider 12 months after the patient's estimated date of delivery
Secondary Rate of visit unscheduled health care visit/encounter by the time of outcome assessment Any visit to a urgent care or emergency room visit 4 months after the patient's estimated date of delivery
Secondary Rate of visit unscheduled health care visit/encounter Any visit to a urgent care or emergency room visit 12 months after the patient's estimated date of delivery
Secondary Rate of contraception plan documented by the time of outcome assessment Contraception plan documented by any provider after delivery 4 months after the patient's estimated date of delivery
Secondary Rate of long-acting contraception use at time of outcome assessment Long-acting contraception use (implant, intrauterine device) 4 months after the patient's estimated date of delivery
Secondary Rate of long-acting contraception use Long-acting contraception use (implant, intrauterine device) 12 months after the patient's estimated date of delivery
Secondary Rate of contraception plan documented Contraception plan documented by any provider after delivery 12 months after the patient's estimated date of delivery
Secondary Rate of pregestational diabetes screening among individuals with gestational diabetes Postpartum diabetes screening among those diagnosed with gestational diabetes 4 months after the patient's estimated date of delivery
Secondary Rate of pregestational diabetes screening among individuals with gestational diabetes Postpartum diabetes screening among those diagnosed with gestational diabetes 12 months after the patient's estimated date of delivery
Secondary Rate of weight counseling documented in the health record among those with obesity Weight counseling documentation among those with obesity 4 months after the patient's estimated date of delivery
Secondary Rate of weight counseling documented in the health record among those with obesity Weight counseling documentation among those with obesity 12 months after the patient's estimated date of delivery
Secondary Rate of blood pressure measurement documented in the health record among those with or at risk for hypertension Blood pressure documented in the EHR among those diagnosed within chronic or pregnancy-related hypertension 4 months after the patient's estimated date of delivery
Secondary Rate of blood pressure measurement documented in the health record among those with or at risk for hypertension Blood pressure documented in the EHR among those diagnosed within chronic or pregnancy-related hypertension 12 months after the patient's estimated date of delivery
Secondary Rate of mental health service referral or use among individuals with mood or anxiety disorders Clinical support services (e.g., social work, psychiatry, therapy) for individuals with mood or anxiety disorders 4 months after the patient's estimated date of delivery
Secondary Rate of mental health service referral or use among individuals with mood or anxiety disorders Clinical support services (e.g., social work, psychiatry, therapy) for individuals with mood or anxiety disorders 12 months after the patient's estimated date of delivery
Secondary Rate of antidepressant use among individuals with mood or anxiety disorders New or continued antidepressant prescription use 4 months after the patient's estimated date of delivery
Secondary Rate of antidepressant use among individuals with mood or anxiety disorders New or continued antidepressant prescription use 12 months after the patient's estimated date of delivery
Secondary Rate of antihypertensive use among individuals with hypertension New or continued antihypertensive medication use among individuals with hypertension 4 months after the patient's estimated date of delivery
Secondary Rate of antihypertensive use among individuals with hypertension New or continued antihypertensive medication use among individuals with hypertension 12 months after the patient's estimated date of delivery
Secondary Rate of medication use for glycemic control among individuals with diabetes New or continued oral or subcutaneous diabetes medication use control among individuals with diabetes 4 months after the patient's estimated date of delivery
Secondary Rate of medication use for glycemic control among individuals with diabetes New or continued oral or subcutaneous diabetes medication use control among individuals with diabetes 12 months after the patient's estimated date of delivery
Secondary Rate of assessment of glycemic control among individuals with or at risk for diabetes Laboratory glucose screening test among individuals with or at risk for diabetes 4 months after the patient's estimated date of delivery
Secondary Rate of assessment of glycemic control among individuals with or at risk for diabetes Laboratory glucose screening test among individuals with or at risk for diabetes 12 months after the patient's estimated date of delivery
Secondary Rate of patient-reported primary care visit attendance Primary care provider visit attendance per patient report 4 months after the patient's estimated date of delivery
Secondary Rate of patient-reported primary care visit attendance Primary care provider visit attendance per patient report 12 months after the patient's estimated date of delivery
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2